logo-loader
viewCereno Scientific AB

Cereno Scientific to begin Phase II clinical trial in Bulgaria and Russia to treat thrombosis

Cereno Scientific AB CEO Sten R. Sörensen sat down with Proactive's Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Swedish company, which is listed on the Spotlight Stock Market, is making headway with its thrombosis prevention therapy CS1.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Ariana Resources says average monthly production at Kiziltepe 'currently...

Ariana Resources PLC's (LON:AAU) Kerim Sener caught up with Proactive London's Andrew Scott to to discuss its quarterly production report from Kiziltepe. He says average monthly production from the gold mine is currently running above target. Sener adds that gold recovery has remained high...

42 minutes ago

2 min read